SALEM INVESTMENT COUNSELORS INC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 75 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
SALEM INVESTMENT COUNSELORS INC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$321
+33.2%
1670.0%0.00%
Q2 2023$241
-31.3%
1670.0%0.00%
Q1 2023$351
+85.7%
1670.0%0.00%
Q4 2022$1891670.0%0.00%
Q3 2022$01670.0%0.00%
Q2 2022$01670.0%0.00%
Q1 2022$01670.0%0.00%
Q4 2021$0
-100.0%
1670.0%0.00%
Q3 2021$1,0000.0%1670.0%0.00%
Q2 2021$1,0001670.0%0.00%
Q1 2021$01670.0%0.00%
Q4 2020$01670.0%0.00%
Q3 2020$0
-100.0%
1670.0%0.00%
Q2 2020$1,0001670.0%0.00%
Q1 2020$01670.0%0.00%
Q4 2019$0
-100.0%
1670.0%0.00%
Q3 2019$1,0000.0%1670.0%0.00%
Q2 2019$1,0000.0%1670.0%0.00%
Q2 2018$1,0000.0%1670.0%0.00%
Q4 2017$1,0001670.0%0.00%
Q2 2017$01670.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$222,0000.08%
Geneos Wealth Management Inc. 478,067$626,0000.03%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$16,0000.01%
Atria Wealth Solutions, Inc. 281,700$369,0000.01%
Vivaldi Capital Management LP 17,078$22,0000.01%
OSAIC HOLDINGS, INC. 1,284,481$1,684,0000.00%
Ameritas Advisory Services, LLC 45,302$59,0000.00%
CENTAURUS FINANCIAL, INC. 20,947$27,0000.00%
Summit Trail Advisors, LLC 23,855$31,0000.00%
WEDBUSH SECURITIES INC 27,998$37,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders